The flow continues with further advances
Microheterogeneity of antithrombin III
Neutrophil activation and morbidity in young adults with cyanotic congenital heart disease
Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli-asparaginase. A Gimema study
A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations
A new variant of interaction between phospholipid antibodies and the protein C system
Levels of fibrinolytic activators and inhibitors in plasma after severe trauma
The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects
Combined factor VIII/factor XI deficiency may cause intra-familial clinical variability in haemophilia A among Ashkenazi Jews
Regulation of thrombin-induced endothelial cell activation by bacterial toxins
Recombinant plasminogen activator inhibitor type 1
Defining the heparin-binding domain of antithrombin
The platelet glycoprotein Ib–IX complex
Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry
Severe bleeding caused by an inhibitor to coagulation factor V
Haemoglobin inhibition of fibrin polymerization and clotting
Responses of autoimmune factor VIII inhibitors to a combination of cyclophosphamide and prednisone
Diet and Heart Disease. A Round Table of Factors
Anticoagulation, Hemostasis and Blood Preservation in Cardiovascular Surgery